CTLA4 and neoplasm: The synergistic potential of physical activity in overcoming resistance to immune checkpoint inhibition was highlighted by the considerable delay in tumor advancement that occurred when exercise was added to this immunotherapeutic regimen, even though therapy with anti-PD-1 and anti-CTLA-4 alone was unable to reduce tumor growth (184).